Conference abstractPublished 19 Dec 2014
The development of response surface pathway design to reduce animal numbers in toxicity studies
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Background: This study describes the development of Response Surface Pathway (RSP) design, assesses its performance and effectiveness in estimating LD50, and compares RSP with Up and Down Procedures (UDPs) and Random Walk (RW) design. Methods: A basic 4-level RSP design was used on 36 male ICR mice given intraperitoneal doses of Yessotoxin. Simulations were performed to optimise the design. A k-adjustment factor was introduced to ensure coverage of the dose window and calculate the dose steps. The performance of the RSP designs and a comparison of UDPs and RW were assessed by simulations. The optimised 4-level RSP design was used on 24 female NMRI mice given Azaspiracid-1 intraperitoneally. Results: The in vivo experiment with basic 4-level RSP design estimated the LD50 of Yessotoxin to be 463 μg/kgBW. By inclusion of the k-adjustment factor with equal or increasing numbers of mice on increasing dose levels, the estimate changed to 481 μg/kgBW and 447 μg/kgBW, respectively. The optimised 4-level RSP estimated the LD50 to be 473 μg/kgBW. The simulations showed that the inclusion of the k-adjustment factor, reduction in sample size and incorporation of a multinomial outcome gave estimates of the LD50 that were as good as those with the basic RSP design. Simulated comparison of the RSP design with UDPs and RW design demonstrated the superiority of RSP. Conclusion: Optimised RSP design reduces the number of animals needed. The design converges rapidly on the area of interest and is at least as efficient as both the UDPs and RW design.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalClinical Pharmacology & Biopharmaceutics
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Stig Larsen”
- BylineArticles whose byline prints “Sagita Dewi”